Targeting the PD-1 Axis with Pembrolizumab for Recurrent or Metastatic Cancer of the Uterine Cervix: A Brief Update

by Yannick Verhoeven, Delphine Quatannens, Xuan Bich Trinh, An Wouters, Evelien L.J. Smits, Filip Lardon, Jorrit De Waele, Peter A. van Dam
Published 2021-02-01

Immuno-PET Molecular Imaging of RANKL in Cancer

by Jonatan Dewulf, Christel Vangestel, Yannick Verhoeven, Jorrit De Waele, Karen Zwaenepoel, Peter A. van Dam, Filipe Elvas, Tim Van den Wyngaert
Published 2021-04-01

Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer

by Andreas Domen, Delphine Quatannens, Sara Zanivan, Christophe Deben, Jonas Van Audenaerde, Evelien Smits, An Wouters, Filip Lardon, Geert Roeyen, Yannick Verhoeven, Annelies Janssens, Timon Vandamme, Peter van Dam, Marc Peeters, Hans Prenen
Published 2021-02-01

RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review

by Peter A. van Dam, Yannick Verhoeven, Julie Jacobs, An Wouters, Wiebren Tjalma, Filip Lardon, Tim Van den Wyngaert, Jonatan Dewulf, Evelien Smits, Cécile Colpaert, Hans Prenen, Marc Peeters, Martin Lammens, Xuan Bich Trinh
Published 2019-05-01